139 related articles for article (PubMed ID: 6214382)
1. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Tarpay MM; Welch DF; Marks MI
Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
4. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
Azimi PH; Dunphy MG
Antimicrob Agents Chemother; 1982 Mar; 21(3):521-4. PubMed ID: 6213193
[TBL] [Abstract][Full Text] [Related]
6. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
McCracken GH; Nelson JD; Grimm L
Antimicrob Agents Chemother; 1982 Feb; 21(2):262-7. PubMed ID: 6280599
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Thabaut A; Durosoir JL; Saliou P
Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Magnussen CR; Sammartino MT; Ernest KD
Antimicrob Agents Chemother; 1982 Jul; 22(1):154-6. PubMed ID: 6289736
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Woolfrey BF; Fox JM; Quall CO
J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
[No Abstract] [Full Text] [Related]
12. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
Traub WH; Leonhard B
Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790
[TBL] [Abstract][Full Text] [Related]
14. Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteria.
Preston DA
Rev Infect Dis; 1982; 4 Suppl():S516-21. PubMed ID: 6296965
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of relatively penicillin-resistant Streptococcus pneumoniae to newer cephalosporin antibiotics.
Bosley GS; Elliott JA; Oxtoby MJ; Facklam RR
Diagn Microbiol Infect Dis; 1987 May; 7(1):21-7. PubMed ID: 3691031
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Matsuo K; Tsuzaki Y; Furukawa S; Uete T
Jpn J Antibiot; 1984 Jun; 37(6):1040-57. PubMed ID: 6387213
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Matsuo K; Uete T
Jpn J Antibiot; 1983 Jul; 36(7):1621-37. PubMed ID: 6317908
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Schaad UB; McCracken GH; Loock CA; Thomas ML
J Infect Dis; 1981 Feb; 143(2):156-63. PubMed ID: 6260870
[TBL] [Abstract][Full Text] [Related]
19. Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Landesman SH; Corrado ML; Cherubin CE; Sierra MF
Antimicrob Agents Chemother; 1981 May; 19(5):794-7. PubMed ID: 6271048
[TBL] [Abstract][Full Text] [Related]
20. [Statistical regression analysis for four new cephalosporins (author's transl)].
Sirot D; Glanddier Y; Chanal M; Sirot J; Cluzel R
Pathol Biol (Paris); 1982 Jun; 30(6):357-62. PubMed ID: 6287389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]